165 related articles for article (PubMed ID: 36572644)
1. Current best clinical practices for monitoring of interstitial lung disease.
Bendstrup E; Kronborg-White S; Møller J; Prior TS
Expert Rev Respir Med; 2022; 16(11-12):1153-1166. PubMed ID: 36572644
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung diseases in the hospitalized patient.
Disayabutr S; Calfee CS; Collard HR; Wolters PJ
BMC Med; 2015 Sep; 13():245. PubMed ID: 26407727
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
Collins BF; Luppi F
Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function testing in interstitial lung diseases.
Chetta A; Marangio E; Olivieri D
Respiration; 2004; 71(3):209-13. PubMed ID: 15133338
[TBL] [Abstract][Full Text] [Related]
7. Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype.
Nili M; Singer D; Hanna M
BMC Pulm Med; 2022 Apr; 22(1):153. PubMed ID: 35459138
[TBL] [Abstract][Full Text] [Related]
8. Artificial Intelligence and Interstitial Lung Disease: Diagnosis and Prognosis.
Dack E; Christe A; Fontanellaz M; Brigato L; Heverhagen JT; Peters AA; Huber AT; Hoppe H; Mougiakakou S; Ebner L
Invest Radiol; 2023 Aug; 58(8):602-609. PubMed ID: 37058321
[TBL] [Abstract][Full Text] [Related]
9. Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases.
Torres PPTES; Rabahi MF; Moreira MADC; Escuissato DL; Meirelles GSP; Marchiori E
J Bras Pneumol; 2021; 47(3):e20200096. PubMed ID: 34076172
[TBL] [Abstract][Full Text] [Related]
10. Home monitoring in interstitial lung diseases.
Wijsenbeek MS; Moor CC; Johannson KA; Jackson PD; Khor YH; Kondoh Y; Rajan SK; Tabaj GC; Varela BE; van der Wal P; van Zyl-Smit RN; Kreuter M; Maher TM
Lancet Respir Med; 2023 Jan; 11(1):97-110. PubMed ID: 36206780
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
12. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
13. Walking the path of treatable traits in interstitial lung diseases.
Amati F; Spagnolo P; Ryerson CJ; Oldham JM; Gramegna A; Stainer A; Mantero M; Sverzellati N; Lacedonia D; Richeldi L; Blasi F; Aliberti S
Respir Res; 2023 Oct; 24(1):251. PubMed ID: 37872563
[TBL] [Abstract][Full Text] [Related]
14. Does the severity of interstitial lung disease affect the gains from pulmonary rehabilitation?
Deniz S; Şahin H; Yalnız E
Clin Respir J; 2018 Jun; 12(6):2141-2150. PubMed ID: 29498799
[TBL] [Abstract][Full Text] [Related]
15. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
Fischer A; Distler J
Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
[TBL] [Abstract][Full Text] [Related]
16. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
[TBL] [Abstract][Full Text] [Related]
17. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.
Wuyts WA; Papiris S; Manali E; Kilpeläinen M; Davidsen JR; Miedema J; Robalo-Cordeiro C; Morais A; Artés M; Asijee G; Cendoya D; Soulard S
Adv Ther; 2020 Jul; 37(7):3246-3264. PubMed ID: 32445186
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
Tanizawa K; Handa T; Kubo T; Chen-Yoshikawa TF; Aoyama A; Motoyama H; Hijiya K; Yoshizawa A; Oshima Y; Ikezoe K; Tokuda S; Nakatsuka Y; Murase Y; Nagai S; Muro S; Oga T; Chin K; Hirai T; Date H
Respir Res; 2018 Aug; 19(1):162. PubMed ID: 30165854
[TBL] [Abstract][Full Text] [Related]
19. Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians.
Nambiar AM; Walker CM; Sparks JA
Ther Adv Respir Dis; 2021; 15():17534666211039771. PubMed ID: 34477452
[TBL] [Abstract][Full Text] [Related]
20. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
